Erlotinib Completed Phase 1 / 2 Trials for Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity / Stage IIIb Non-small Cell Lung Cancer / Recurrent Squamous Cell Carcinoma of the Nasopharynx / Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity / Untreated Metastatic Squamous Neck Cancer With Occult Primary / Stage IV Verrucous Carcinoma of the Larynx / Stage IV Adenoid Cystic Carcinoma of the Oral Cavity / Stage IV Rectal Cancer / Recurrent Basal Cell Carcinoma of the Lip / Recurrent Squamous Cell Carcinoma of the Hypopharynx / Stage IV Renal Cell Cancer / Stage IV Squamous Cell Carcinoma of the Nasopharynx / Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity / Stage IV Inverted Papilloma of the Paranasal Sinus and Nasal Cavity / Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma / Stage III Squamous Cell Carcinoma of the Hypopharynx / Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Stage III Salivary Gland Cancer / Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Stage IV Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity / Recurrent Salivary Gland Cancer / Recurrent Colon Cancer / Recurrent Lymphoepithelioma of the Nasopharynx / Stage III Lymphoepithelioma of the Oropharynx / Recurrent Lymphoepithelioma of the Oropharynx / Stage III Squamous Cell Carcinoma of the Larynx / Stage IV Lymphoepithelioma of the Nasopharynx / Recurrent Verrucous Carcinoma of the Larynx / Stage IV Lymphoepithelioma of the Oropharynx / Stage IV Salivary Gland Cancer / Recurrent Adenoid Cystic Carcinoma of the Oral Cavity / Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity / Stage IV Squamous Cell Carcinoma of the Larynx / Stage III Verrucous Carcinoma of the Oral Cavity / Stage IV Basal Cell Carcinoma of the Lip / Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity / Recurrent Rectal Cancer / Stage III Adenoid Cystic Carcinoma of the Oral Cavity / Recurrent Verrucous Carcinoma of the Oral Cavity / Stage III Pancreatic Cancer / Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity / Stage IV Squamous Cell Carcinoma of the Oropharynx / Stage III Squamous Cell Carcinoma of the Nasopharynx / Metastatic Colon Cancer / Stage III Rectal Cancer / Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity / Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity / Stage III Mucoepidermoid Carcinoma of the Oral Cavity / Stage III Lymphoepithelioma of the Nasopharynx / Stage IV Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity / Recurrent Mucoepidermoid Carcinoma of the Oral Cavity / Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity / Stage IV Verrucous Carcinoma of the Oral Cavity / Stage III Squamous Cell Carcinoma of the Oropharynx / Stage IV Mucoepidermoid Carcinoma of the Oral Cavity / Recurrent Pancreatic Cancer / Stage IV Non-Small Cell Lung Cancer / Stage III Verrucous Carcinoma of the Larynx / Stage IV Pancreatic Cancer / Stage III Colon Cancer / Recurrent Squamous Cell Carcinoma of the Oropharynx / Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity / Stage III Basal Cell Carcinoma of the Lip / Recurrent Squamous Cell Carcinoma of the Larynx / Non-Small Cell Lung Cancer Recurrent / Recurrent Metastatic Squamous Neck Cancer With Occult Primary / Stage IV Squamous Cell Carcinoma of the Hypopharynx Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00088959Celecoxib and Erlotinib in Treating Former Smokers With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT01839955Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer